The bad news is we might just be kicking the can down the road without bold, creative strategies to truly redefine the future of how we care for elderly in our state. Click here to […]
The data breach was discovered June 1, a day after an employee received a phishing email to compromise the account and an unauthorized person received access to files that included personal health information of the […]
One is a successful Pittsburgh-region manufacturer, the other the president of a western Pennsylvania college. Click here to view original post
As data sharing has become more helpful and relevant to researchers in the past few years, a new report in JAMA Oncology shows that the availability of cancer drugs’ clinical trial data is still lagging […]
Beyond the back and forth of whether Democrats’ drug price negotiation plan is necessary to bring down costs, or just a thinly veiled attempt at price controls, the nuts and bolts of the deal mean […]
This week’s Lab Notes has updates from AmerisourceBergen, Marken, Strata Skin Sciences, Neuronetics and Nexgel. Click here to view original post
Seattle-based Icosavax was one of the companies in the rat race to develop Covid-19 vaccine shots better than Pfizer and Moderna. However, when clinical trials showed that its vaccine candidate, IVX-411, fared ‘below expectations,” the […]
Bristol Myers Squibb has hit a snag in its Phase III trial investigating the company’s Opdivo and Yervoy combo in renal cell carcinoma, or RCC. Researchers had been investigating Opdivo and Yervoy together as a […]
Nine years after doling out $50 million upfront to Merck, it appears AstraZeneca’s work in the WEE1 inhibitor space is over. The UK Big Pharma has ended two studies of adavosertib, a Phase I trial […]
Company founded in 2018 by University of Pittsburgh and UPMC Hillman Cancer Center resesarchers. Click here to view original post
Copyright © 2023 Biotech Networks, LLC
